mcePharma recieved grant from European Union
Company mcePharma s.r.o. obtained a subsidy from the Operational Program Enterprise and Innovation for Competitiveness for the implementation of the project: Research and development of a food supplement in the form of an orally soluble tablet with proven increased bioavailability and containing unsaturated Omega-3 fatty acids, project number: CZ.01.1.02 / 0.0 / 0.0 / 17_175 / 0015458.
This subsidy from the European Union will enable the company to implement a project aimed at developing a dietary supplement containing unsaturated Omega 3 fatty acids in the form of ODT with scientifically proven bioavailability. After completion of the project implementation, the applicant will then be able to offer its customers a unique new product, which will be unique in its form.